Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers H > Headlines for Human Genome Sciences Inc. > News item |
Human Genome Sciences to buy back convertibles with $200 million offering proceeds
Pittsburgh, Sept. 27 - Human Genome Sciences Inc. will use net proceeds from its offering of $200 million of new convertible subordinated notes to buy back a portion of its outstanding convertible subordinated debt from time to time, according to a company news release.
The new deal also includes a 30-day, $50 million over-allotment option.
Human Genome Sciences is based in Rockville, Md.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.